Latvia
Sequent Scientific Ltd (BOM:512529) Q4 2024 Earnings Call Transcript Highlights: Record EBITDA and Margin Expansion
EBITDA pre-ESOP cost: INR411 million for Q4 FY24, highest in the last 12 quarters.EBITDA Margin pre-ESOP cost: 11.4% for Q4 FY24, expanded by 220 bps quarter-o